The contract manufacturing organisation (CMO) said that the facility will provide its customers with primary and secondary packaging services for pharmaceutical solid and liquid oral dosage forms, including both tablets and capsules.
Medis highlighted the plant’s Uhlmann high-speed blistering line as a key feature, claiming that the unit will save its customers both time and money.
Medis business development manager Petr Bulej said that US Food and Drug Administration (FDA) and European Union approved good manufacturing practice (GMP) accreditation is anticipated in Q4.
